Which policies for vaccine innovation and delivery in Europe?

Mathias Dewatripont

International Journal of Industrial Organization, 2022, vol. 84, issue C

Abstract: This paper analyzes the subsequent steps of the covid vaccine experience in the European Union. It stresses the features of the US innovation ecosystem which were responsible for its success. It argues that the European Union did reasonably well in procuring vaccines and logistically organizing their delivery but that vaccine hesitancy proved to be a key constraint. The paper discusses European countries’ vaccination strategies and their plusses and minusses. Finally, it draws some lessons for dealing with the tradeoff between drug and vaccine innovation and affordability, an issue whose importance is bound to grow with promising but costly scientific advances.

Keywords: Vaccine innovation; Covid-19; Innovation ecosystem; Vaccine hesitancy; Drug prices; European health policy (search for similar items in EconPapers)
JEL-codes: I11 I18 L32 L65 O31 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0167718722000340
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:indorg:v:84:y:2022:i:c:s0167718722000340

DOI: 10.1016/j.ijindorg.2022.102858

Access Statistics for this article

International Journal of Industrial Organization is currently edited by P. Bajari, B. Caillaud and N. Gandal

More articles in International Journal of Industrial Organization from Elsevier
Bibliographic data for series maintained by Catherine Liu ().